Convalescent Plasma Therapy in Late-State, Severe COVID-19 Infection-Reference-Cited by-同舟云学术

Convalescent Plasma Therapy in Late-State, Severe COVID-19 Infection

Published:2023-05 Issue:5 Volume:116 Page:427-433
ISSN:1541-8243
Container-title:Southern Medical Journal
language:en
Short-container-title:

Author:

Kumar Neil R.,Karanam Veena C.,Kumar Shari,Kumar Sunil D.

Publisher

Southern Medical Association

Subject

General Medicine

Reference18 articles.

1. Johns Hopkins University & Medicine, Coronavirus Resource Center. COVID-19 dashboard. https://coronavirus.jhu.edu/map.html. Accessed January 19, 2023.

2. Association between administration of systemic corticosteroids and mortality among critically ill patients with COVID-19: a meta-analysis;WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group;JAMA

3. Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19 (COV-BARRIER): a randomised, double-blind, parallel-group, placebo-controlled phase 3 trial;Lancet Respir Med

4. Treatment of coronavirus disease 2019 patients with convalescent plasma reveals a signal of significantly decreased mortality;Am J Pathol

5. Significantly decreased mortality in a large cohort of coronavirus disease 2019 (COVID-19) patients transfused early with convalescent plasma containing high-titer anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein IgG;Am J Pathol

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Convalescent Plasma for Critically-ill Covid-19 Patients;2024-02-02

2. Commentary on “Convalescent Plasma Therapy in Late-State, Severe COVID-19 Infection”;Southern Medical Journal;2023-05